-- 
Pronova Starts Dosing in Phase I Clinical Trial of PRC-4016

-- B y   M e e r a   B h a t i a
-- 
2011-09-19T08:55:26Z

-- http://www.bloomberg.com/news/2011-09-19/pronova-starts-dosing-in-phase-i-clinical-trial-of-prc-4016.html
Pronova BioPharma ASA started
dosing in a Phase I clinical trial of PRC-4016, a new chemical
entity for the treatment of combined dyslipidemia.  To contact the editor responsible for this story:
Meera Bhatia at 
 mbhatia2@bloomberg.net  